Considerations for Optimal Trial Design for Rheumatoid Arthritis Prevention Studies - Clinical Therapeutics
Phase 3 Trial Finds AbbVie's Rheumatoid Arthritis Drug Effective
Rheumatology Clinal Research - Carolina Arthritis
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes - ScienceDirect
Tofacitinib phase III clinical trials in moderate to severe rheumatoid... | Download Scientific Diagram
Transforming clinical trials in rheumatology: towards patient-centric precision medicine | Nature Reviews Rheumatology
Novel rheumatoid arthritis drug succeeds in clinical trial | News Center | Stanford Medicine
Tripterygium wilfordii Hook F. versus Sulfasalazine in the treatment of rheumatoid arthritis: A well-designed clinical trial of a botanical demonstrating effectiveness - ScienceDirect
Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2022